Light Horse Therapeutics
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$62M
Light Horse Therapeutics develops small molecule therapeutics using a proprietary platform that identifies novel functional domains in disease-critical targets.
Focus Areas
Small molecule therapeutics
drug discovery
proprietary platform
disease-critical targets
innovative approach.
Investors
